Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IQCC and CCDC28B antisense RNA 1 (IQCC-AS1) is a putative antisense long non-coding RNA transcribed from the opposite strand of the IQCC and/or CCDC28B gene locus. Antisense lncRNAs are a subclass of long non-coding RNAs that can regulate the expression of their corresponding protein-coding genes through multiple mechanisms, including modulation of mRNA stability, translation, or epigenetic modification. While many antisense lncRNAs have been shown to play functional roles in cancer and other diseases, the specific molecular and functional characterization of IQCC-AS1 has not been established. The nomenclature “IQCC and CCDC28B antisense RNA 1” is nonstandard; normally, an antisense RNA is attributed to a single sense gene. The absence of further information indicates either the target is not established or the name is erroneous.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IQCC and CCDC28B antisense RNA 1 (IQCC-AS1).